Perspectives: Knock-Off Ozempic Could Be Dangerous; Does Your OTC Decongestant Really Work?
Read recent commentaries about pharmaceutical issues.
The Washington Post:
Beware Of Knockoff Weight-Loss Drugs
Americans are so desperate to get their hands on popular weight-loss drugs such as Ozempic and Wegovy that many are turning to knockoff versions. Doing so could come with real harm. (Leana S. Wen, 10/24)
USA Today:
FDA Says The Decongestant In Your Medicine Cabinet Probably Doesn't Work. Now What?
Just before cold and flu season is set to kick off, the Food and Drug Administration's advisory panel last month reported that an oral decongestant Americans have relied on for nearly 20 years is no better than a placebo. (Jeffery Singer, 10/25)
Modern Healthcare:
High Drug Costs Could Be Reduced With Collaboration
America spends more on drugs and prescription medications, on average, than any other country. And it doesn’t matter where those drugs are purchased. Hospital drug spending is up 30% to 40% since 2019, outpacing increases in labor costs and other supplies. Prescription medications are a unique American burden as well. (Dr. Bruce Meyer and Jim Benedict, 10/25)
The Washington Post:
Don’t Let Drug Companies Get Out Of Negotiating Prices
In recent months, drug manufacturers and their allies have filed 10 lawsuits attacking one of the Inflation Reduction Act’s core health policy achievements: its plan for Medicare to negotiate drug prices. (C. Joseph Ross Daval and Aaron S. Kesselheim, 10/23)
